| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 18, 2023 | Dec 21, 2023 | TScan Therapeutics, Inc. | Director | Buy | 95.0 | +29,147 | 40.97% | ✗ | $142.5K |
| Jun 2, 2023 | Jun 6, 2023 | TScan Therapeutics, Inc. | Director | Buy | 95.0 | +37,880 | 113.89% | ✗ | $99.6K |
| Dec 4, 2020 | Dec 7, 2020 | Verastem, Inc. | Director | Buy | 95.0 | +50,000 | 29.76% | ✗ | $108.5K |
| Mar 15, 2019 | Mar 19, 2019 | Verastem, Inc. | Director | Buy | 95.0 | +33,000 | 24.44% | ✗ | $105.9K |
| Sep 28, 2018 | Oct 2, 2018 | Verastem, Inc. | Director | Buy | 83.8 | +5,000 | 3.85% | ✗ | $36.6K |
| Dec 5, 2017 | Dec 7, 2017 | Verastem, Inc. | Director | Buy | 95.0 | +60,538 | 87.15% | ✗ | $239.1K |
| May 15, 2017 | May 17, 2017 | Verastem, Inc. | Director | Buy | 95.0 | +30,000 | 76.02% | ✗ | $73.5K |
| Jan 28, 2015 | Jan 28, 2015 | Verastem, Inc. | Director | Buy | 97.5 | +38,462 | 3846.20% | ✗ | $250K |
| May 30, 2014 | Jun 2, 2014 | Verastem, Inc. | Director | Buy | 90.0 | +1,000 | 100.00% | ✗ | $9.9K |